So let's turn to page seven.
In the quarter, we saw underlying growth in both business areas of 4%, offset by ended contract exits and FX headwinds, which resulted in reported net sales decreasing 3% to 4.7 billion compared to last year. Adjusting for currency, the overall growth was fairly flat, indicating that currency had a 3% impact on total sales in Scandinavia. The underlying growth was 3% and reported as down 5%. We see continued growth in our own nursing homes. However, growth was more than offset by the ending of outsourcing and home care contracts. In Finland, the underlying growth, excluding divested units, was 4.4% and 3% in local currency. With an increase in new customers and all key segments showing positive growth. Currency had, as expected, a larger 3% negative sales effect in the quarter, and based on current trading, we should expect a similar to slightly lower effect in the coming quarter.
Slide eight please. The reported result improved to 349 million, one of our strongest Q2 results ever.
Correspondingly, the adjusted EBITA increased from 163 to 205, up 26% versus the same period last year.
This business's adjusted EBITDA in Scandinavia was slightly lower than last year. Negatively impacted by exit costs in home care, some start-up costs in new homes, and Easter seasonality.
Finland's adjusted EBITDA improved by €52 million, with currency having a €13 million reported and €9 million negative effect on this adjusted EBITDA. Next slide please. The underlying growth was 4.4%. The adjusted EBITDA was 183 million, an improvement of 52 million compared to last year. The quarter improved with better staffing and more sold beds. Occupancy rate also improved versus last year, with more sold beds and from exiting a few low occupancy units during the year. In the quarter, we also opened a new home and added new capacity within existing units.
Next slide please. However, growth was more than offset by the termination of outsourcing and exiting home care contracts, resulting in a total growth decrease of 5% year over year. The adjusted EBITA was 44 million. We delivered despite some startup costs, continuing to improve results in our nursing homes. Our new home in Stockholm, which opened in March, is developing well.
And in June, we opened an additional new nursing home, which is off to a good start.
Ended outsourcing contracts had no material impact on results.
However, as mentioned in Q1, we terminated a few selected home care contracts where sustainable conditions no longer exist. In Q2, these contracts had a 20 million non-recurring negative impact on the results, slightly higher than the estimated effect communicated in Q1.
Going forward, we expect less, but still some negative impact in Q3 and subsequently lower impact in Q4. While we delivered results in line with last year when adjusting for one-off effects in both this and last year's quarters, the outcome is not satisfactory. Scandinavia has more to give and ongoing actions are expected to improve performance. Finally, in line with our strategy, we signed an agreement to acquire Främja, which will further strengthen our unique and disabled care offering.
The acquisition has a revenue of approximately 150 million and above-average margins, and is expected to close at the end of Q3. Slide 11 please. During Q2, the free cash flow was 316 million compared to 199 million. Last year, CapEx was at similar levels compared to last year, and during the quarter, we paid out our dividend of 1.26 per share, which impacted the cash flow by 179 million at the beginning of the quarter. We also made share repurchases worth 36 million. And today, we launched a new repurchase program aiming to repurchase 150 million worth of shares until the next quarterly report in October. Next slide please. As a result, we have utilized approximately 70% of our free cash flow for dividends and continuous share buybacks. In addition, we have continued to add high-quality, value-accretive bolt-ons. Firstly, in Finland, Q1 this year, and we aim to continue with this strategy, adding further value-accretive bolt-ons. During the rest of the year.
Also worth mentioning is that during the quarter, we agreed with our banks to increase our revolving credit facility from 1.4 billion to 2 billion SEK.
This will enable us to increase our financial flexibility and ensure we have enough room to maneuver in order to deliver on strategic initiatives and, overall, our active capital allocation strategy. Next slide please. If we start at the top left, the adjusted earnings per share improved by 0.7 cents, up 25% versus last year. Improvement primarily due to higher adjusted EBITDA and further supported by our continuous share buybacks.
If we turn to the top right figure and our latest adjusted margin in percent, adjusted for non-recurring items last year, we continue to improve our results. Adjusted EBITDA margin in Q2, the rolling 12-month margin was 5.8%, up 1.2 percentage points compared to Q2 last year.
And if we look at the figure at the bottom left, our lowest adjusted net debt to EBITDA ratio was 1.7, in the lower part of our target range of 1.5 to 2.5, and down 0.5 times versus the same quarter last year. And finally, if we look at the figure on the bottom right. Net interest expenses in the quarter were 31 million, in line with last quarter, where we see the effects of improved market interest rates.
With that, I hand over to you, Martin.